Scholarlink

This case describes the feasibility of 177Lu-DOTATATE (Lutathera®) in the treatment of a refractory WHO grade 2 meningioma, and its contribution with a decrease in tumor growth rate.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Case 34: Somatostatin Receptor Therapy in a Grade II Meningioma

  • 章节

  • 发表日期：

    2025年

查看全文
  • Tatiana Horowitz,
  • Thomas Graillon,
  • Betty Salgues,
  • Eric Guedj

摘要

This case describes the feasibility of 177Lu-DOTATATE (Lutathera®) in the treatment of a refractory WHO grade 2 meningioma, and its contribution with a decrease in tumor growth rate.